Pulmonary and Critical Care Medicine Research and Clinical Trials
The Division has a varied and growing research program in a number of important areas, including both basic and clinical sciences. Our team is focused on cutting-edge research into the causes and treatments of diseases of the airway and lungs such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis (IPF), asthma and much more. That research is implemented at the University of Maryland Medical Center (UMMC), giving hope and often improved outcomes to critically and chronically ill patients.
A brief description and appropriate links are available for each program by selecting any of the links below:
Basic Research Programs:
- Acute Lung Injury
- Asthma
- Innate Immunity of the Lung
- Interstitial Pulmonary Fibrosis
- Inflammation Research Group
- Mucosal Biology Research Center
- Sepsis
- Cardiac Effects of Chronic Intermittent Hypoxia
Clinical Research Programs:
- Effects of mechanical ventilation
- Effects of Anti-TNF therapy in COPD
- Pharmacogenetics of asthma/Corticosteroid resistance
- University of Maryland Airway Research Center
- National Emphysema Treatment Trial (NETT)
- Mechanisms of Interstitial Lung Disease
- Feasibility of Retinoic Acid in the Treatment of Emphysema (FORTE)
- COPD Clinical Research Network
- Lung Cancer
- Combined Medical-Surgical Critical Care Clinical Research Program
Contact Us
Studies open frequently. To learn more about our ongoing clinical trials, you can call 410-328-8141.
